Sex steroids and bone

Recent Progress in Hormone Research

Volumn 57, Issue , 2002, Pages 385-409

  Manolagas, S C ^a   Kousteni, S ^a   Jilka, R L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BONE GROWTH; BONE REMODELING; HORMONE ACTION; HUMAN; LIGAND BINDING; METABOLIC REGULATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BONE AND BONES; BONE DEVELOPMENT; FEMALE; GONADAL STEROID HORMONES; HUMANS; INTERLEUKIN-6; MALE; OSTEOBLASTS; OSTEOCLASTS;

EID: 0036377536     PISSN: 00799963     EISSN: None     Source Type: Journal    
DOI: 10.1210/rp.57.1.385     Document Type: Article

References (100)

1. Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: The role of the androgen receptor
2. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells
3. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation
4. WAF1.CIP1,SDI1 gene by interleukin-6 type cytokines - A prerequisite for their prodifferentiating and anti-apoptotic effects on human osteoblastic cells
5. Protein kinase A-dependent phosphorylation and inactivation of the pro-apoptotic protein Bad mediates the anit-apoptotic effect of PTH on osteoblastic cells
6. Estrogen binding and estrogenic responses in normal human osteoblast-like cells
7. 1(I)-procollagen and transforming growth factor-β steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells
8. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
9. Preliminary evidence for impaired estrogen receptor-alpha protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis
10. Effect of testosterone and estradiol in a man with aromatase deficiency
11. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha
12. Osteoporosis among estrogen-deficient women - United States, 1988-1994
13. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae
14. 17beta-estradiol and ICI-182780 regulate the hair follicle cycle in mice through an estrogen receptor-alpha pathway
15. Mammalian MAP kinase signalling cascades
16. BCL-2 family: Regulators of cell death
17. Gender-independent induction of murine osteoclast apoptosis in vitro by either estrogens or non-aromatizable androgens
18. Estrogen receptor null mice: What have we learned and where will they lead us?
19. Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats
20. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol
21. The transit amplifying mesenchymal progenitor cell compartment, not the stem cell compartment, is the principal site of control of osteoblast production in normal and pathologic bone remodeling
22. Evidence of estrogen receptors in normal human osteoblast-like cells
23. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women
24. Growth and estrogen
25. Probing conformational changes in the estrogen receptor: Evidence for a partially unfolded intermediate facilitating ligand binding and release
26. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in-vitro: A potential mechanism for the antiosteoporotic effect of estrogens
27. Interleukin-11: A new cytokine critical for osteoclast development
28. Estrogen: Consequences and implications of human mutations in synthesis and action
29. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
30. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
31. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β
32. Cytokines, bone remodeling, and estrogen deficiency: A 1998 update
33. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
34. Estrogen loss upregulates hematopoiesis in the mouse: A mediating role of interleukin-6
35. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence
36. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: Evidence for autonomy from factors released during bone resorption
37. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines
38. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
39. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells
40. Non-genotropic, sex non-specific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
41. Generation of osteoclasts from isolated hematopoietic progenitor cells
42. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow
43. Stem cells and cellular pedigrees - A conceptual introduction
44. Putative mechanism for PGE2 anabolic effects: Indomethacin administered in vivo induces apoptosis in alkaline positive bone marrow cells
45. The role of IL-6 type cytokines and their receptors in bone
46. Cell number versus cell vigor - What really matters to a regenerating skeleton?
47. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
48. Corticosteroids and fractures: A close encounter of the third cell kind
49. Manipulating programmed cell death for better living!
50. Cytokines, hematopoiesis, osteoclastogenesis, and estrogens
51. Mechanisms of disease: Bone marrow, cylokines, and bone remodeling - Emerging insights into the pathophysiology of osteoporosis
52. Perspective: Nonreproductive sites of action of reproductive hormones
53. New developments in the pathogenesis and treatment of steroid-induced osteoporosis
54. Estrogens, cytokines, and the pathophysiology of osteoporosis
55. Interleukin-6-type cytokines and their receptors
56. Parathyroid hormone and corticosteroid-induced osteoporosis
57. Extranuclear functions of sex steroid receptors, kinases and osteoporosis: Leads from improved HRT
58. The molecular pharmacology of SERMs
59. Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone
60. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring
61. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
62. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
63. Isolation and characterization of the human gp130 promoter - Regulation by STATs
64. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
65. The pathophysiologic roles of interleukin-6 in human disease
66. Genetic effects on bone mass and turnover-relevance to black/white differences
67. Osteoporosis: 50 years of change, mostly in the right direction
68. Misconceptions (1): Epiphyseal fusion causes cessation of growth
69. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
70. Structural and cellular changes during bone growth in healthy children
71. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal
72. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
73. Connexin-43 hemichannel opening: A requirement for bishophonate-mediated prevention of osteocyte apoptosis
74. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
75. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism
76. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells
77. Estrogen signals to the preservation of endothelial cell form and function
78. Gender differences in acute CNS trauma and stroke: Neuroprotective effects of estrogen and progesterone
79. Estrogen replacement therapy. A survey of older women's attitudes
80. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause
81. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population
82. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha
83. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
84. Genetic mutations resulting in estrogen insufficiency in the male
85. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
86. Caveolin-enriched membrane signaling complexes in human and murine osteoblasts
87. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of egr-1 and its interaction with Sp-1
88. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
89. Estrogen's bone-protective effects may involve differential IL-I receptor regulation in human osteoclast-like cells
90. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage
91. Ovariectomy causes cell proliferation and matrix synthesis in the growth plate cartilage of the adult rat
92. 5α-dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomized rats
93. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone
94. The role of estrogen in the control of rat osteocyte apoptosis
95. Novel mechanisms of estrogen action in the brain: New players in an old story
96. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage
97. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: Potential mechanisms of their deleterious effects on bone
98. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip